Works matching DE "GLUCAGON-like peptide 1"
Results: 2993
Perioperative Practice Patterns of Anaesthesiologists Surrounding Glucagon-Like Peptide-1 (GLP-1) Agonist Medications.
- Published in:
- Turkish Journal of Anaesthesiology & Reanimation, 2025, v. 53, n. 2, p. 42, doi. 10.4274/TJAR.2025.241653
- By:
- Publication type:
- Article
Amylin analogs for the treatment of obesity without diabetes: present and future.
- Published in:
- Expert Review of Clinical Pharmacology, 2024, v. 17, n. 10, p. 891, doi. 10.1080/17512433.2024.2409403
- By:
- Publication type:
- Article
Pharmacological management of testosterone deficiency in men current advances and future directions.
- Published in:
- Expert Review of Clinical Pharmacology, 2024, v. 17, n. 8, p. 665, doi. 10.1080/17512433.2024.2366505
- By:
- Publication type:
- Article
Ocular adverse events associated with GLP-1 receptor agonists: a real-world study based on the FAERS database and network pharmacology.
- Published in:
- Expert Opinion on Drug Safety, 2025, v. 24, n. 3, p. 287, doi. 10.1080/14740338.2024.2419989
- By:
- Publication type:
- Article
The preclinical discovery and clinical evaluation of tirzepatide for the treatment of type 2 diabetes.
- Published in:
- Expert Opinion on Drug Discovery, 2024, v. 19, n. 5, p. 511, doi. 10.1080/17460441.2024.2324918
- By:
- Publication type:
- Article
Environmental factors related to the origin and evolution of differentiated thyroid cancer: a narrative review.
- Published in:
- Expert Review of Endocrinology & Metabolism, 2024, v. 19, n. 6, p. 469, doi. 10.1080/17446651.2024.2377687
- By:
- Publication type:
- Article
Advances in the treatment of functional male hypogonadism.
- Published in:
- Expert Review of Endocrinology & Metabolism, 2024, v. 19, n. 2, p. 163, doi. 10.1080/17446651.2023.2296022
- By:
- Publication type:
- Article
The "entanglement" between bullous pemphigoid and diabetes mellitus: a comprehensive review and expert recommendations.
- Published in:
- Expert Review of Clinical Immunology, 2025, v. 21, n. 3, p. 333, doi. 10.1080/1744666X.2024.2428621
- By:
- Publication type:
- Article
Are post-exercise plasma glucose elevations involved in exercise-induced appetite suppression?
- Published in:
- Applied Physiology, Nutrition & Metabolism, 2025, v. 50, p. 1, doi. 10.1139/apnm-2024-0331
- By:
- Publication type:
- Article
Unravelling the ties that bind: The intersection of obesity, osteoarthritis, and inflammatory pathways with emphasis on glucagon‐like peptide‐1 agonists.
- Published in:
- Clinical Obesity, 2025, v. 15, n. 1, p. 1, doi. 10.1111/cob.12700
- By:
- Publication type:
- Article
Elective peri‐operative management of adults taking glucagon‐like peptide‐1 receptor agonists, glucose‐dependent insulinotropic peptide agonists and sodium‐glucose cotransporter‐2 inhibitors: a multidisciplinary consensus statement: A consensus statement from the Association of Anaesthetists, Association of British Clinical Diabetologists, British Obesity and Metabolic Surgery Society, Centre for Perioperative Care, Joint British Diabetes Societies for Inpatient Care, Royal College of Anaesthetists, Society for Obesity and Bariatric Anaesthesia and UK Clinical Pharmacy Association
- Published in:
- Anaesthesia, 2025, v. 80, n. 4, p. 412, doi. 10.1111/anae.16541
- By:
- Publication type:
- Article
Routine peri‐operative cessation of glucagon‐like peptide‐1 receptor agonists has unintended consequences.
- Published in:
- Anaesthesia, 2025, v. 80, n. 3, p. 339, doi. 10.1111/anae.16509
- By:
- Publication type:
- Article
Insights into the Roles of GLP-1, DPP-4, and SGLT2 at the Crossroads of Cardiovascular, Renal, and Metabolic Pathophysiology.
- Published in:
- Cells (2073-4409), 2025, v. 14, n. 5, p. 387, doi. 10.3390/cells14050387
- By:
- Publication type:
- Article
RE: Glucagon-like peptide 1 receptor agonists and pancreatic cancer risk: target trial emulation using real-world data.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2025, v. 117, n. 3, p. 562, doi. 10.1093/jnci/djae324
- By:
- Publication type:
- Article
Chronic kidney disease management in primary care: challenges and possible developments.
- Published in:
- 2025
- By:
- Publication type:
- Editorial
Paradigm shift in obesity treatment: an extensive review of current pipeline agents.
- Published in:
- Turkish Journal of Medical Sciences, 2025, v. 55, n. 1, p. 1, doi. 10.55730/1300-0144.5938
- By:
- Publication type:
- Article
The Impact of Obesity Treatments on Bone Health: Insights from Recent Research.
- Published in:
- Journal of Obesity & Metabolic Syndrome, 2025, v. 34, n. 1, p. 1, doi. 10.7570/jomes25001
- By:
- Publication type:
- Article
Turner's Syndrome, Glucagon-like Peptide 1, and Glucose-dependent Insulinotropic Polypeptide Agents: Silver Bullets?
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2025, v. 110, n. 3, p. e901, doi. 10.1210/clinem/dgae435
- By:
- Publication type:
- Article
Substituting Carbohydrate at Lunch for Added Protein Increases Fat Oxidation During Subsequent Exercise in Healthy Males.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2025, v. 110, n. 3, p. e728, doi. 10.1210/clinem/dgae237
- By:
- Publication type:
- Article
Glucagon-Like Peptide 1 Receptor (Glp1r) Deficiency Does Not Appreciably Alter Airway Inflammation or Gut-Lung Microbiome Axis in a Mouse Model of Obese Allergic Airways Disease and Bariatric Surgery.
- Published in:
- Journal of Asthma & Allergy, 2025, v. 18, p. 285, doi. 10.2147/JAA.S478329
- By:
- Publication type:
- Article
Sweet Solutions: Unlocking the Diabetes-Dementia Connection for Better Outcomes.
- Published in:
- Journal of Insurance Medicine, 2025, v. 52, n. 1, p. 14, doi. 10.17849/insm-52-1-14-20.1
- By:
- Publication type:
- Article
Integration of Glucagon-Like Peptide 1 Receptor Actions Through the Central Amygdala.
- Published in:
- Endocrinology, 2025, v. 166, n. 3, p. 1, doi. 10.1210/endocr/bqaf019
- By:
- Publication type:
- Article
Association between GLP-1 RAs and DPP-4 inhibitors with biliary disorders: pharmacovigilance analysis.
- Published in:
- Frontiers in Pharmacology, 2025, p. 1, doi. 10.3389/fphar.2025.1509561
- By:
- Publication type:
- Article
Changes in food preferences after oral semaglutide administration in Japanese patients with type 2 diabetes: KAMOGAWA-DM cohort.
- Published in:
- Diabetes & Vascular Disease Research, 2025, v. 22, n. 1, p. 1, doi. 10.1177/14791641251318309
- By:
- Publication type:
- Article
Enhancing Tetrahydrocannabinol's Therapeutic Efficacy in Inflammatory Bowel Disease: The Roles of Cannabidiol and the Cannabinoid 1 Receptor Allosteric Modulator ZCZ011.
- Published in:
- Pharmaceuticals (14248247), 2025, v. 18, n. 2, p. 148, doi. 10.3390/ph18020148
- By:
- Publication type:
- Article
Sodium–Glucose Cotransporter 2 Inhibitors and Lower-Extremity Amputation: Is the Guilty Verdict Valid?
- Published in:
- Diabetes Care, 2025, v. 48, n. 3, p. 338, doi. 10.2337/dci24-0101
- By:
- Publication type:
- Article
Response to Comment on Foss-Freitas et al. Efficacy and Safety of Glucagon-Like Peptide 1 Agonists in a Retrospective Study of Patients With Familial Partial Lipodystrophy. Diabetes Care 2024;47:653–659.
- Published in:
- 2025
- By:
- Publication type:
- Letter
One Size Does Not Fit All: Understanding Microdosing Semaglutide for Diabetes in Multidose Pens.
- Published in:
- 2025
- By:
- Publication type:
- Letter
Exploring Kidney Oxygenation Responses to Dapagliflozin, Exenatide, and Their Combination in Patients With Type 2 Diabetes and Chronic Kidney Disease: Observations From a Prespecified Pilot Study of a Randomized Crossover Trial.
- Published in:
- 2025
- By:
- Publication type:
- Letter
Glucagon-Like Peptide 1 Receptor Agonists and Sodium–Glucose Cotransporter 2 Inhibitors and the Prevention of Cirrhosis Among Patients With Type 2 Diabetes.
- Published in:
- Diabetes Care, 2025, v. 48, n. 3, p. 444, doi. 10.2337/dc24-1903
- By:
- Publication type:
- Article
Prescribing Trends of Glucose-Lowering Medications Near End of Life Among Adults With Type 2 Diabetes: A Cohort Study.
- Published in:
- Diabetes Care, 2025, v. 48, n. 3, p. 455, doi. 10.2337/dc24-1795
- By:
- Publication type:
- Article
Comment on Foss-Freitas et al. Efficacy and Safety of Glucagon-Like Peptide 1 Agonists in a Retrospective Study of Patients With Familial Partial Lipodystrophy. Diabetes Care 2024;47:653–659.
- Published in:
- 2025
- By:
- Publication type:
- Letter
Comparative Efficacy of Glucagon-Like Peptide 1 Receptor Agonists for Cardiovascular Outcomes in Asian Versus White Populations: Systematic Review and Meta-analysis of Randomized Trials of Populations With or Without Type 2 Diabetes and/or Overweight or Obesity
- Published in:
- Diabetes Care, 2025, v. 48, n. 3, p. 489, doi. 10.2337/dc24-1533
- By:
- Publication type:
- Article
Capsaicin (But Not Other Vanillins) Enhances Estrogen Binding to Its Receptor: Implications for Power Sports and Cancers.
- Published in:
- Life (2075-1729), 2025, v. 15, n. 2, p. 208, doi. 10.3390/life15020208
- By:
- Publication type:
- Article
The Incretin Effect of Yerba Maté (Ilex paraguariensis) Is Partially Dependent on Gut-Mediated Metabolism of Ferulic Acid.
- Published in:
- Nutrients, 2025, v. 17, n. 4, p. 625, doi. 10.3390/nu17040625
- By:
- Publication type:
- Article
Postprandial Adiponectin Levels Are Associated with Improvements in Postprandial Triglycerides After Roux-en-Y Gastric Bypass in Type 2 Diabetic Patients.
- Published in:
- Metabolic Syndrome & Related Disorders, 2013, v. 11, n. 5, p. 343, doi. 10.1089/met.2012.0042
- By:
- Publication type:
- Article
The Vagotomy Alleviates the Anorectic Effect of an Excess Amount of Dietary Leucine on Rats Fed a Low-Protein Diet.
- Published in:
- Bioscience, Biotechnology & Biochemistry, 2013, v. 77, n. 7, p. 1593, doi. 10.1271/bbb.130150
- By:
- Publication type:
- Article
One-Step Purification of a Fusion Protein of Glucagon-Like Peptide-1 and Human Serum Albumin Expressed in Pichia pastoris by an Immunomagnetic Separation Technique.
- Published in:
- Bioscience, Biotechnology & Biochemistry, 2007, v. 71, n. 11, p. 2655, doi. 10.1271/bbb.70190
- By:
- Publication type:
- Article
High-Level Expression of Fusion Protein Containing 10 Tandem Repeated GLP-1 Analogs in Yeast Pichia pastoris and Its Biological Activity in a Diabetic Rat Model.
- Published in:
- Bioscience, Biotechnology & Biochemistry, 2007, v. 71, n. 6, p. 1462, doi. 10.1271/bbb.60694
- By:
- Publication type:
- Article
The Design of a GLP‐1/PYY Dual Acting Agonist.
- Published in:
- Angewandte Chemie, 2021, v. 133, n. 15, p. 8349, doi. 10.1002/ange.202016464
- By:
- Publication type:
- Article
International Accolades for GLP-1 Research: Recognizing Pioneers in Diabetes and Obesity Treatment Across Five Prestigious Awards.
- Published in:
- Cardiovascular Drugs & Therapy, 2025, v. 39, n. 1, p. 9, doi. 10.1007/s10557-024-07630-9
- By:
- Publication type:
- Article
Liraglutide Protects Against Diastolic Dysfunction and Improves Ventricular Protein Translation.
- Published in:
- Cardiovascular Drugs & Therapy, 2024, v. 38, n. 6, p. 1289, doi. 10.1007/s10557-023-07482-9
- By:
- Publication type:
- Article
Dipeptidyl Peptidase-4 Inhibitor Decreases Allograft Vasculopathy Via Regulating the Functions of Endothelial Progenitor Cells in Normoglycemic Rats.
- Published in:
- Cardiovascular Drugs & Therapy, 2021, v. 35, n. 6, p. 1111, doi. 10.1007/s10557-020-07013-w
- By:
- Publication type:
- Article
Predictors of efficacy of Sodium‐GLucose Transporter‐2 inhibitors and Glucagon‐Like Peptide 1 receptor agonists: A retrospective cohort study.
- Published in:
- Diabetes/Metabolism Research & Reviews, 2024, v. 40, n. 2, p. 1, doi. 10.1002/dmrr.3727
- By:
- Publication type:
- Article
The new dual gastric inhibitory peptide/glucagon‐like peptide 1 agonist tirzepatide in type 2 diabetes: Is the future bright?
- Published in:
- Diabetes/Metabolism Research & Reviews, 2021, v. 37, n. 8, p. 1, doi. 10.1002/dmrr.3503
- By:
- Publication type:
- Article
Switching from insulin to dulaglutide therapy in patients with type 2 diabetes: A real-world data study.
- Published in:
- 2021
- By:
- Publication type:
- journal article
The Mediterranean diet increases glucagon‐like peptide 1 and oxyntomodulin compared with a vegetarian diet in patients with type 2 diabetes: A randomized controlled cross‐over trial.
- Published in:
- Diabetes/Metabolism Research & Reviews, 2021, v. 37, n. 6, p. 1, doi. 10.1002/dmrr.3406
- By:
- Publication type:
- Article
Glucose‐lowering pharmacotherapies in Chinese adults with type 2 diabetes and cardiovascular disease or chronic kidney disease. An expert consensus reported by the Chinese Diabetes Society and the Chinese Society of Endocrinology.
- Published in:
- Diabetes/Metabolism Research & Reviews, 2021, v. 37, n. 4, p. 1, doi. 10.1002/dmrr.3416
- By:
- Publication type:
- Article
The use of GLP-1 receptor agonists in hospitalised patients: An untapped potential.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Glucagon-like peptide-1 receptor agonists in type 2 diabetes treatment: are they all the same?
- Published in:
- 2019
- By:
- Publication type:
- journal article